7-41690536-G-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_002192.4(INHBA):c.395C>A(p.Ala132Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000213 in 1,594,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_002192.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INHBA | NM_002192.4 | c.395C>A | p.Ala132Asp | missense_variant | 3/3 | ENST00000242208.5 | NP_002183.1 | |
INHBA | XM_017012174.2 | c.395C>A | p.Ala132Asp | missense_variant | 3/3 | XP_016867663.2 | ||
INHBA | XM_047420335.1 | c.395C>A | p.Ala132Asp | missense_variant | 4/4 | XP_047276291.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INHBA | ENST00000242208.5 | c.395C>A | p.Ala132Asp | missense_variant | 3/3 | 1 | NM_002192.4 | ENSP00000242208.4 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152046Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000430 AC: 1AN: 232656Hom.: 0 AF XY: 0.00000795 AC XY: 1AN XY: 125720
GnomAD4 exome AF: 0.0000229 AC: 33AN: 1442656Hom.: 0 Cov.: 33 AF XY: 0.0000181 AC XY: 13AN XY: 716432
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152046Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74266
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 22, 2024 | The c.395C>A (p.A132D) alteration is located in exon 3 (coding exon 2) of the INHBA gene. This alteration results from a C to A substitution at nucleotide position 395, causing the alanine (A) at amino acid position 132 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at